A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 46 (5), 1105-1108
- https://doi.org/10.1016/s0360-3016(99)00532-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancerRadiotherapy and Oncology, 1998
- 106 Conventional radiotherapy as primary treatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week-report from the Dahanca 7 trialInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Very accelerated radiation therapy: Preliminary results in locally unresectable head and neck carcinomasInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunctionInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Antimutagenic Effects of Radioprotector WR-2721 Against Fission-spectrum Neutrons and60Co γ-rays in MiceInternational Journal of Radiation Biology, 1992
- Radiation Protectors: the Unexpected BenefitsDrug Metabolism Reviews, 1989
- Final report on phase i trial of WR-2721 before protracted fractionated radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Long-term effects of radioprotector WR-2721 on locomotor activity and body weight of mice following exposure to ionizing radiationToxicology, 1988
- Fractionation studies with WR-2721: Normal tissues and tumourRadiotherapy and Oncology, 1986
- Effect of tumor type, size, and endpoint on tumor radioprotection by WR-2721International Journal of Radiation Oncology*Biology*Physics, 1984